Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gavin C. Bowick is active.

Publication


Featured researches published by Gavin C. Bowick.


Vaccine | 2010

Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity.

Thomas P. Monath; Cynthia K. Lee; Justin G. Julander; Alicja Brown; David W. C. Beasley; Douglas M. Watts; Edward G. Hayman; Patrick M. Guertin; Joseph Makowiecki; Joseph D. Crowell; Philip Levesque; Gavin C. Bowick; Merribeth Morin; Elizabeth Fowler; Dennis W. Trent

In the last 10 years new concerns have arisen about safety of the live, attenuated yellow fever (YF) 17D vaccine, in particular viscerotropic adverse events, which have a case-fatality rate of 64%. A non-replicating cell culture-based vaccine would not cause these adverse events, and potentially could be used in persons with precautions or contraindications to use of the live vaccine, including age <9 months and >60 years, egg allergy, immune suppression, and pregnancy. We developed a whole virion vaccine from the 17D strain inactivated with beta-propiolactone, and adsorbed to aluminum hydroxide. The inactivated vaccine was highly immunogenic in mice, hamsters, and cynomolgus macaques. After a single dose in hamsters and macaques, neutralizing antibody titers were similar to those elicited by the live 17D vaccine (YF-VAX, Sanofi Pasteur). After two doses of inactivated vaccine, neutralizing antibody titers in hamsters were significantly higher than after a single dose of YF-VAX [geometric mean titer (GMT) 20,480 vs. 1940, respectively (P<0.001, ANOVA)]. Hamsters given a single dose or two doses of inactivated vaccine or a single dose of YF-VAX were fully protected against hepatitis, viremia, weight loss and death after challenge with YF virus (Jimenez strain). A clinical trial of the inactivated vaccine (XRX-001) has been initiated.


Journal of Virology | 2007

Identification of Differentially Activated Cell-Signaling Networks Associated with Pichinde Virus Pathogenesis by Using Systems Kinomics

Gavin C. Bowick; Susan M. Fennewald; Erin P. Scott; Lihong Zhang; Barry L. Elsom; Judith F. Aronson; Heidi Spratt; Bruce A. Luxon; David G. Gorenstein; Norbert K. Herzog

ABSTRACT Phosphorylation plays a key role in regulating many signaling pathways. Although studies investigating the phosphorylated forms of signaling pathways are now commonplace, global analysis of protein phosphorylation and kinase activity has lagged behind genomics and proteomics. We have used a kinomics approach to study the effect of virus infection on host cell signaling in infected guinea pigs. Delineating the host responses which lead to clearance of a pathogen requires the use of a matched, comparative model system. We have used two passage variants of the arenavirus Pichinde, used as a biosafety level 2 model of Lassa fever virus as it produces similar pathologies in guinea pigs and humans, to compare the host cell responses between infections which lead to either a mild, self-limiting infection or lethal disease. Using this model, we can begin to understand the differences in signaling events which give rise to these markedly different outcomes. By contextualizing these data using pathway analysis, we have identified key differences in cellular signaling matrices. By comparing these differentially involved networks, we have identified a number of key signaling “nodes” which show differential phosphorylations between mild and lethal infections. We believe that these nodes provide potential targets for the development of antiviral therapies by acting at the level of the host response rather than by directly targeting viral proteins.


Journal of Leukocyte Biology | 2009

Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1

Alison Hogg; Gavin C. Bowick; Norbert K. Herzog; Miles W. Cloyd; Janice J. Endsley

Immunosuppression following infection with HIV‐1 predisposes patients to a myriad of opportunistic pathogens, one of the most important of which is Mtb. Granulysin, expressed by NK cells and CTL, exhibits potent antimicrobial activity against Mtb and several other opportunistic pathogens associated with HIV‐1 infection. The immune signals that promote granulysin expression in human CTL are not fully understood. Using primary human CD8+ T cells, in this study, we identify IL‐21 as a strong inducer of granulysin, demonstrate that IL‐21 and IL‐15 activate granulysin expression within CD8+ CD45RO+ T cells, and establish a role for Jak/STAT signaling in the regulation of granulysin within CD8+ T cells. We show that infection of PBMC from healthy donors in vitro with HIV‐1 suppresses granulysin expression by CD8+ T cells, concomitant with reduced p‐STAT3 and p‐STAT5, following activation with IL‐15 and IL‐21. Of note, simultaneous signaling through IL‐15 and IL‐21 could partially overcome the immunosuppressive effects of HIV‐1 on granulysin expression by CD8+ T cells. These results suggest that HIV‐1 infection of PBMC may reduce the antimicrobial profile of activated CD8+ T cells by disrupting signaling events that are critical for the induction of granulysin. Understanding the effects of HIV‐1 on CD8+ T cell activation is essential to understanding the physiological basis for inadequate cytotoxic lymphocyte activity in HIV+ patients and for informed guidance of cytokine‐based therapy to restore T cell function.


Journal of Virology | 2006

Differential Signaling Networks Induced by Mild and Lethal Hemorrhagic Fever Virus Infections

Gavin C. Bowick; Susan M. Fennewald; Barry L. Elsom; Judith F. Aronson; Bruce A. Luxon; David G. Gorenstein; Norbert K. Herzog

ABSTRACT The family Arenaviridae includes several National Institutes of Allergy and Infections Diseases category A select agents which cause hemorrhagic fever. There are few vaccines available, and treatment is limited to ribavirin, which varies in efficacy. Development of new antiviral compounds has been hindered by a lack of understanding of the molecular basis of pathogenesis. We used two variants of Pichinde virus, one attenuated and one virulent in the guinea pig model, to delineate the host determinants which lead to either viral clearance or lethal disease. By analyzing protein level changes using pathway analysis, we have identified key intermediates which may be targets for therapeutic intervention.


Virology Journal | 2012

Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever

Gavin C. Bowick; Adriana M. Airo; Dennis A. Bente

BackgroundCrimean Congo hemorrhagic fever (CCHF) is a tick-borne hemorrhagic zoonosis associated with high mortality. Pathogenesis studies and the development of vaccines and antivirals against CCHF have been severely hampered by the lack of suitable animal model. We recently developed and characterized a mature mouse model for CCHF using mice carrying STAT1 knockout (KO).FindingsGiven the importance of interferons in controlling viral infections, we investigated the expression of interferon pathway-associated genes in KO and wild-type (WT) mice challenged with CCHF virus. We expected that the absence of the STAT1 protein would result in minimal expression of IFN-related genes. Surprisingly, the KO mice showed high levels of IFN-stimulated gene expression, beginning on day 2 post-infection, while in WT mice challenged with virus the same genes were expressed at similar levels on day 1.ConclusionsWe conclude that CCHF virus induces similar type I IFN responses in STAT1 KO and WT mice, but the delayed response in the KO mice permits rapid viral dissemination and fatal illness.


Viral Immunology | 2009

Attenuated and lethal variants of pichindé virus induce differential patterns of NF-κB activation suggesting a potential target for novel therapeutics

Gavin C. Bowick; Susan M. Fennewald; Lihong Zhang; Xianbin Yang; Judith F. Aronson; Robert E. Shope; Bruce A. Luxon; David G. Gorenstein; Norbert K. Herzog

Lassa virus pathogenesis is believed to involve dysregulation of cytokines. We have previously shown nuclear factor-kappaB (NF-kappaB) inhibition using a BSL-2 model for Lassa fever. Here we further define the potential mechanism for NF-kappaB inhibition as involving increased levels of repressive p50/p50 homodimers, and suggest a novel therapeutic strategy that acts via modulation of host signaling.


Journal of Virology | 2009

Analysis of the Differential Host Cell Nuclear Proteome Induced by Attenuated and Virulent Hemorrhagic Arenavirus Infection

Gavin C. Bowick; Heidi Spratt; Alison Hogg; Janice J. Endsley; John E. Wiktorowicz; Alexander Kurosky; Bruce A. Luxon; David G. Gorenstein; Norbert K. Herzog

ABSTRACT Arenaviruses are important emerging pathogens and include a number of hemorrhagic fever viruses classified as NIAID category A priority pathogens and CDC potential biothreat agents. Infection of guinea pigs with the New World arenavirus Pichindé virus (PICV) has been used as a biosafety level 2 model for the Lassa virus. Despite continuing research, little is known about the molecular basis of pathogenesis, and this has hindered the design of novel antiviral therapeutics. Modulation of the host response is a potential strategy for the treatment of infectious diseases. We have previously investigated the global host response to attenuated and lethal arenavirus infections by using high-throughput immunoblotting and kinomics approaches. In this report, we describe the differential nuclear proteomes of a murine cell line induced by mock infection and infection with attenuated and lethal variants of PICV, investigated by using two-dimensional gel electrophoresis. Spot identification using tandem mass spectrometry revealed the involvement of a number of proteins that regulate inflammation via potential modulation of NF-κB activity and of several heterogeneous nuclear ribonuclear proteins. Pathway analysis revealed a potential role for transcription factor XBP-1, a transcription factor involved in major histocompatibility complex II (MHC-II) expression; differential DNA-binding activity was revealed by electrophoretic mobility shift assay, and differences in surface MHC-II expression were seen following PICV infection. These data are consistent with the results of several previous studies and highlight potential differences between transcriptional and translational regulation. This study provides a number of differentially expressed targets for further research and suggests that key events in pathogenesis may be established early in infection.


BioMed Research International | 2010

Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha.

Gavin C. Bowick; Kizhake V. Soman; He-ling Wang; Judith F. Aronson; Bruce A. Luxon; Lee Lomas; David G. Gorenstein; Norbert K. Herzog

The arenaviruses include a number of important pathogens including Lassa virus and Junin virus. Presently, the only treatment is supportive care and the antiviral Ribavirin. In the event of an epidemic, patient triage may be required to more effectively manage resources; the development of prognostic biomarker signatures, correlating with disease severity, would allow rational triage. Using a pair of arenaviruses, which cause mild or severe disease, we analyzed extracts from infected cells using SELDI mass spectrometry to characterize potential biomarker profiles. EDGE analysis was used to analyze longitudinal expression differences. Extracts from infected guinea pigs revealed protein peaks which could discriminate between mild or severe infection, and between times post-infection. Tandem mass-spectrometry identified several peaks, including the transcriptional regulator prothymosin-α. Further investigation revealed differences in secretion of this peptide. These data show proof of concept that proteomic profiling of host markers could be used as prognostic markers of infectious disease.


Future Virology | 2008

Exploring kinase inhibitors as therapies for human arenavirus infections

Eric M. Vela; Gavin C. Bowick; Norbert K. Herzog; Judith F. Aronson

Arenaviruses are rodent-borne RNA viruses, and some have the capacity to cause hemorrhagic fever and death in infected individuals and thus have been identified as a potential bioterrorism threat. Ribavirin and supportive care are currently the approved therapeutic options for individuals suffering from arenavirus-induced hemorrhagic fever. However, new research has suggested that immune plasma treatment or kinase inhibitors may provide a therapeutic option for treating arenavirus infections in humans. This article puts forth a perspective as to the potential use of kinase inhibitors as an antiviral therapeutic for arenavirus infections.


Viruses | 2011

Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection

Gavin C. Bowick; Alexander J. McAuley

The continuing use of high-throughput assays to investigate cellular responses to infection is providing a large repository of information. Due to the large number of differentially expressed transcripts, often running into the thousands, the majority of these data have not been thoroughly investigated. Advances in techniques for the downstream analysis of high-throughput datasets are providing additional methods for the generation of additional hypotheses for further investigation. The large number of experimental observations, combined with databases that correlate particular genes and proteins with canonical pathways, functions and diseases, allows for the bioinformatic exploration of functional networks that may be implicated in replication or pathogenesis. Herein, we provide an example of how analysis of published high-throughput datasets of cellular responses to hemorrhagic fever virus infection can generate additional functional data. We describe enrichment of genes involved in metabolism, post-translational modification and cardiac damage; potential roles for specific transcription factors and a conserved involvement of a pathway based around cyclooxygenase-2. We believe that these types of analyses can provide virologists with additional hypotheses for continued investigation.

Collaboration


Dive into the Gavin C. Bowick's collaboration.

Top Co-Authors

Avatar

Norbert K. Herzog

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Bruce A. Luxon

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

David G. Gorenstein

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Judith F. Aronson

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Susan M. Fennewald

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Alexander J. McAuley

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Alison Hogg

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Barry L. Elsom

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Dennis A. Bente

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Eric M. Vela

Battelle Memorial Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge